Medistim ASA (FRA:MD1) ROCE % : 29.82% (As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Medistim ASA ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Medistim ASA's annualized ROCE % for the quarter that ended in Sep. 2024 was 29.82%.

Medistim ASA ROCE % Historical Data

The historical data trend for Medistim ASA's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medistim ASA ROCE % Chart

Medistim ASA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

37.84

32.42

38.08

40.68

32.53

Medistim ASA Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															36.52	26.31	33.36	39.60	29.82

Medistim ASA ROCE % Calculation

Medistim ASA's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	11.766	/	( ( (46.116 - 9.538)	+	(43.959 - 8.196) )	/ 2 )
	=	11.766	/	( (36.578	+	35.763)	/ 2 )
	=	11.766	/	36.1705
	=	32.53 %

Medistim ASA's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	10.388	/	( ( (41.731 - 7.146)	+	(41.646 - 6.568) )	/ 2 )
	=	10.388	/	( ( 34.585	+	35.078 )	/ 2 )
	=	10.388	/	34.8315
	=	29.82 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Medistim ASA (FRA:MD1) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Medistim ASA ROCE % Related Terms

Thank you for viewing the detailed overview of Medistim ASA's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Medistim ASA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medistim ASA (FRA:MD1) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

MEDIO:Sweden MEDI:Norway 0OCD:UK

Address

Okernveien 94, Oslo, NOR, 0579

Website

https://www.medistim.com

Medistim ASA is a medical device company. It is engaged in researching, developing, producing, distributing, and sales of medical equipment through its own business or participation in other companies, as well as related activities. The company's business is focused on cardiac and vascular surgery. The group operates in the USA, Europe, Asia, and the Rest of the World. The firm's activity is split into three strategic operating units, Capital equipment; Lease of equipment, and Distribution and sales of third-party products.

Medistim ASA Headlines

No Headlines